InvestSMART

Imricor Medical Systems Inc (ASX: IMR) - Announcements

Current share price for IMR : $1.795 0.03 (1.64%)+

ASX company news and announcements for Imricor Medical Systems Inc (IMR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imricor Medical Systems Inc (IMR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imricor Medical Systems Inc (IMR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imricor Medical Systems Inc (IMR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$644 Proposed issue of securities - IMR 14 Sep 2022 9:22AM $0.285 $1.795 risen by 529.82%
$644 Successful Completion of A$2.92 million Placement 14 Sep 2022 9:13AM $0.285 $1.795 risen by 529.82%
$644 H1 FY22 Results Investor Presentation 31 Aug 2022 8:19AM $0.375 $1.795 risen by 378.67%
$644 Imricor releases Half Year Results for 1H 2022 31 Aug 2022 8:12AM $0.375 $1.795 risen by 378.67%
$644 Appendix 4D and Half Year Report & Accounts 31 Aug 2022 8:10AM $0.375 $1.795 risen by 378.67%
$644 Updated Date for Release of HY Results and Webinar 24 Aug 2022 11:25AM $0.390 $1.795 risen by 360.26%
$644 Appendix 3Y - SW 23 Aug 2022 10:20AM $0.430 $1.795 risen by 317.44%
$644 Notification of cessation of securities - IMR 23 Aug 2022 8:41AM $0.430 $1.795 risen by 317.44%
$644 Notification regarding unquoted securities - IMR 23 Aug 2022 8:38AM $0.430 $1.795 risen by 317.44%
$644 Investor Presentation 18 Aug 2022 4:38PM $0.440 $1.795 risen by 307.95%
$644 Investor Webinar 18 Aug 2022 4:38PM $0.440 $1.795 risen by 307.95%
$644 Details of 1H22 Results Investor Webinar 17 Aug 2022 9:16AM $0.390 $1.795 risen by 360.26%
$644 Response to ASX Price Query 15 Aug 2022 9:12AM $0.425 $1.795 risen by 322.35%
$644 Appendix 4C - Quarterly Report and Business Update 28 Jul 2022 8:04AM $0.310 $1.795 risen by 479.03%
$644 Details of Q4 Appendix 4C Investor Webinar 19 Jul 2022 9:58AM $0.315 $1.795 risen by 469.84%
$644 Change of Auditor 8 Jul 2022 10:16AM $0.320 $1.795 risen by 460.94%
$644 Submission of 2nd Gen Ablation Catheter for EU Approval 5 Jul 2022 10:01AM $0.270 $1.795 risen by 564.81%
$644 Change in substantial holding 28 Jun 2022 1:59PM $0.175 $1.795 risen by 925.71%
$644 Imricor Signs Siemens Agreements and Businss Update 28 Jun 2022 9:40AM $0.150 $1.795 risen by 1,096.67%
$644 Appendix 3Y - PM 23 Jun 2022 9:57AM $0.125 $1.795 risen by 1,336%
$644 Appendix 3Y - MT 23 Jun 2022 9:55AM $0.125 $1.795 risen by 1,336%
$644 Appendix 3Y - AM 23 Jun 2022 9:55AM $0.125 $1.795 risen by 1,336%
$644 Change in substantial holding 23 Jun 2022 8:22AM $0.125 $1.795 risen by 1,336%
$644 Ceasing to be a substantial holder 22 Jun 2022 4:53PM $0.125 $1.795 risen by 1,336%
$644 Change in substantial holding 22 Jun 2022 8:22AM $0.115 $1.795 risen by 1,460.87%

351 - 375 of 600 results

Page 15 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.